Results 51 to 60 of about 5,127,009 (325)

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status

open access: yesMilitary Medical Research, 2020
An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received worldwide attention.
Yanrong Guo   +8 more
semanticscholar   +1 more source

The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea [PDF]

open access: yesOsong Public Health and Research Perspectives
The COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination.
Na-Young Jeong   +14 more
doaj   +1 more source

Characteristics of SARS-CoV-2 and COVID-19

open access: yesNature Reviews Microbiology, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, named ‘coronavirus disease 2019’ (COVID-19), which ...
Ben Hu, Hua Guo, P. Zhou, Zhènglì Shí
semanticscholar   +1 more source

Of chloroquine and COVID-19

open access: yesAntiviral Research, 2020
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
Touret, Franck, de Lamballerie, Xavier
openaire   +4 more sources

Acceptability and feasibility of strategies to shield the vulnerable during the COVID-19 outbreak: a qualitative study in six Sudanese communities

open access: yesBMC Public Health, 2021
Background Shielding of high-risk groups from coronavirus disease (COVID-19) has been suggested as a realistic alternative to severe movement restrictions during the COVID-19 epidemic in low-income countries. The intervention entails the establishment of
Nada Abdelmagid   +6 more
doaj   +1 more source

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

open access: yesRadiology, 2020
Background Chest CT is used for diagnosis of 2019 novel coronavirus disease (COVID-19), as an important complement to the reverse-transcription polymerase chain reaction (RT-PCR) tests. Purpose To investigate the diagnostic value and consistency of chest
T. Ai   +8 more
semanticscholar   +1 more source

Evaluation of self-administered antigen testing in a college setting

open access: yesVirology Journal, 2022
Background The objective of our investigation was to better understand barriers to implementation of self-administered antigen screening testing for SARS-CoV-2 at institutions of higher education (IHE).
Sarah C. Tinker   +21 more
doaj   +1 more source

COVID-19 and Diabetes [PDF]

open access: yesJournal of Clinical Medicine, 2021
Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on patients with DM hospitalized because of COVID-19 show that glycemic control is inadequate.
Virginia Bellido, Antonio Pérez
openaire   +3 more sources

Quantitative comparison of SARS-CoV-2 nucleic acid amplification test and antigen testing algorithms: a decision analysis simulation model

open access: yesBMC Public Health, 2022
Background Antigen tests for SARS-CoV-2 offer advantages over nucleic acid amplification tests (NAATs, such as RT-PCR), including lower cost and rapid return of results, but show reduced sensitivity.
Phillip P. Salvatore   +6 more
doaj   +1 more source

Procalcitonin as a Predictive Factor for the Clinical Outcome of Patients with Coronavirus Disease 2019 [PDF]

open access: yesJournal of Acute Care Surgery, 2022
Purpose The coronavirus disease 2019 (COVID-19) pandemic continues. It has been reported that patients with bacterial coinfection have a higher mortality rate than patients without coinfection.
Sungho Lee   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy